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Background: Hantaviruses are emerging zoonotic pathogens which cause hemorrhagic fever with renal syndrome,
an immune-mediated pathogenesis is discussed. The aim of the present study was to investigate the role of TGF-β
expression in acute hantavirus infection.
Results: We retrospectively studied 77 patients hospitalised with acute Puumala infection during a hantavirus
epidemic in Germany in 2012. Hantavirus infection was confirmed by positive anti-Puumala hantavirus IgG and IgM.
Plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 were analysed. Based on glomerular filtration rate
on admission, patients were divided in mild and severe course of disease. Puumala virus RNA was detected by PCR
amplification of the viral L segment gene. Out of 77 Puumala virus infected patients, 52 (68%) were male. A seasonal
distribution was detected in our cohort with a peak in summer 2012, the highest incidence was observed in the
age group of 30–39 years. Puumala virus RNA was detectable in 4/77 cases. Patients with severe disease had a
significant longer hospital stay than patients with mild disease (6.2 vs 3.6 days). Thrombocyte count (186 vs 225 per
nl), serum TGF-β1 (74 vs 118 ng/l) and TGF-β2 (479 vs 586 pg/l) were significantly lower in severe compared to mild
disease. However, C-reactive protein (CRP) was significantly higher in patients with severe disease (62 vs 40 mg/l).
TGF-β1/Cr was the most sensitive and specific marker associated with renal dysfunction.
Conclusion: High serum CRP and low serum TGF-β in the early phase of hantavirus infection is associated with a severe
course of disease. Our results support the hypothesis of an immune-mediated pathogenesis in hantavirus infection.
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Three main clinical syndromes can be distinguished after
hantavirus infection, i.e. hemorrhagic fever with renal
syndrome (HFRS) mainly caused by Seoul, Puumala and
Dobrava viruses; nephropathia epidemica, a mild form of
HFRS caused by Puumala virus; and hantavirus cardio-
pulmonary syndrome, which may be caused by Andes
virus and Sin Nombre virus. There is no curative treat-
ment for hantavirus infection, and eliminating or mini-
mising contact with rodents is the best way to prevent
infection [1]. The case fatality rate of HFRS varies from
<1% to 12% depending on the virus type [2]. Over 50
000 nephropathia epidemica cases with Puumala virus
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unless otherwise stated.175 000 in Western Russia [3]. Approximately 150,000
to 200,000 humans are hospitalized each year because of
hantavirus infections worldwide [2]. European hantavi-
ruses of the family Bunyaviridae cause HFRS. Infection
in humans occurs through inhalation of aerosolised virus
particles from excreta of chronically infected wild rodents
[4]. Puumala is reported throughout most of Europe (ex-
cluding the Mediterranean region) wheras Dobrava, car-
ried by the yellow-necked mouse (Apodemus flavicollis)
and Saaremaa, carried by the striped field mouse (Apode-
mus agrarius), are reported mainly in eastern and central
Europe [5]. In Germany, several hantaviruses pathogenic
for humans are circulating, i.e. Puumala virus, Dobrava
virus and Tula virus [6,7]. Puumala virus is carried by the
bank vole (Clethrionomys glareolus) and leads mostly to a
mild form of disease [3].
The course of HFRS is highly variable, ranging from fre-
quently asymptomatic to a lethal outcome. Host geneticl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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symptoms are high fever, headache, abdominal pain, back-
ache and nausea or vomiting. Proteinuria, haematuria
and acute kidney injury are signs of renal involvement.
Classically, HFRS occurs in five distinct phases: febrile,
hypotensive, oliguric, polyuric and convalescent [8]. A se-
vere course of disease comprises oliguria, high blood cre-
atinine and a high leukocyte count [9], the disease severity
depends on the hantavirus genotype. A minority of pa-
tients needs transient dialysis treatment, but complete re-
covery is the usual outcome [10,11]. Outinen et al. defined
the severity of hantavirus infection by serum creatinine
and thrombocytes count [12]. The role of immune re-
sponse and cytokine expression during Puumala virus in-
fection has been described previously [13,14]. Techniques
for the identification of novel hantaviruses by specific cell
culture models had been established [15]. Only few cases
of Puumala virus infection with severe disease had been
reported for Germany recently [16,17].
In the year 2012, the highest number of human hanta-
virus infections were observed and more than 2800 cases
were reported, 30% of these infections were located in
Southwestern Germany. Case numbers started to rise
earlier during the year than had been reported in previ-
ous epidemics in 2007 and 2010, and are the largest ever
reported in this region [18,19]. The early rise might be
associated with a birch mast year in 2011, followed by
an early and massive reproduction of the reservoir of
bank vole populations during winter 2011 and spring
2012 [20]. However, a possible influence of climate
change on the survival, emergence and epidemiology of
hantaviruses is difficult to predict [21].
It has been suggested that viral load and immunological
factors including cytokines are involved in the pathogen-
esis of Puumala virus infection. The extent and level of
viremia depends largely on the hantavirus type, viral load
is considerably lower in HFRS caused by Puumala virus
when compared to other hantaviruses. Thus viral load
clearly plays a role in disease pathogenesis [8]. In a recent
study, patients infected with Dobrava virus were found to
have a higher viral load than Puumala infected patients
[13]. The aim of this study was to analyse TGF-ß serum
levels in patients with hantavirus infection and to evaluate
the level of TGF-ß in mild and severe course of disease.
Results
Patient characteristics and clinical findings
On admission, all study patients were seropositive for
anti-Puumala IgG and IgM antibodies. Out of 77 pa-
tients with acute Puumala virus infection, 52 (68%) were
male. A seasonal distribution of hantavirus infection was
detected in our cohort and for nationwide cases with a
peak in summer 2012. Age distribution showed a higher
percentage of patients in the age groups of 20–39 (48.1%vs 33.1%; p < 0.05) years and a lower percentage of
patients in the age groups of 40–59 (32.5% vs 48.0%;
p < 0.05) years in our cohort compared to nationwide
data (Figure 1). In contrast to the highest incidence in
the age group of 40–49 (28.1% vs 15.6%; p < 0.05) years
nationwide, our study patients demonstrated the highest
proportion in the age group of 30–39 years (24.7% vs
18.0%; p > 0.05, not significant).
For all patients mean hospitalization time was 4.9 days.
On admission, demographic data and clinical symptoms
such as fever, myalgia, and headache were similar in pa-
tients with mild and severe disease (Table 1). However,
patients with a severe course of disease defined by a
glomerular filtration rate (GFR) of <30 ml/min had
significantly longer hospital stay (6.2 vs 3.6 days) and
significantly higher proteinuria levels (1.3 vs 0.6 g/l)
compared to patients with mild disease, respectively.
The most common symptoms reported on admission
were myalgia, fever, headache, shivering, low back pain,
and arthralgia (Table 1). All patients had impaired renal
function to some degree on admission with an increase
in retention parameters over the course of disease, six
patients (8%) required intermittent hemodialysis.
Correlation of cytokine expression with disease severity
On admission, CRP was increased (62 vs 40 mg/l), a
similar finding was observed for creatinine (5.6 vs. 2.4)
in patients with severe and mild disease, respectively.
Interestingly, patients with severe disease had signifi-
cantly lower TGF-β1 and TGF-β2 serum levels than pa-
tients with mild disease, suggesting an association of
TGF-ß1 and TGF-ß2 with disease severity (Table 2). All
patients had non-detectable TGF-β3 serum levels. The
course of cytokine levels for TGF-ß1, TGF-ß2, as well as
CRP and thrombocyte count on admission and one week
after admission to the hospital is shown in Figure 2 and
Table 3. TGF-ß1 and TGF-ß2 concentrations on admis-
sion imply a stronger TGF-ß1 and TGF-ß2 production
in patients with severe than in patients with mild disease
(Figure 2). Both patient groups had similar CRP level
and thrombocyte count one week after admission. Cre-
atinine remained significantly higher in patients with se-
vere disease during follow-up (data not shown). ROC
curve analysis was performed for TGF-β1, TGF-β2 as
well as for TGF-β1/Cr and TGF-β2/Cr ratios on admis-
sion. TGF-β1/Cr ratio showed the best association with
severe disease, followed by TGF-β1/Cr ratio (Figure 3).
Phylogenetic analysis of puumala virus
For phylogenetic analysis, samples positive for hanta-
virus RNA were sequenced in the hantavirus S-segment.
The data revealed no unique hantavirus strain in these
patients. The sequence data indicate a heterogeneous
strain reservoir in Southwest Germany, some hantavirus
Figure 1 Seasonality (A) and age distribution (B) of hantavirus infections in Germany (white bars) and our study cohort (black bars).
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the Spessart forest or the Bavarian forest (Figure 4).
Discussion
Pathogenesis of hantavirus is not well understood, but
most likely virus-mediated, host-mediated mechanismsTable 1 Clinical data of Puumala virus infected patients
with mild and severe disease on admission
Parameters Mild disease
(n = 38)
Severe disease
(n = 39)
p-value
age in years (mean ± SD) 39.2 ± 15.5 42.7 ± 16.9 0.34
male 63.2% 71.8% 0.42
hospital stay (days ± SD) 3.6 ± 3.6 6.2 ± 3.4 0.001
myalgia 87% 87% 0.69
fever 84% 82% 0.80
headache 84% 82% 0.80
shivering 82% 80% 0.82
low back pain 82% 74% 0.45
arthralgia 71% 87% 0.27
stomach ache 63% 56% 0.74
nausea 58% 54% 0.72
vomiting 42% 33%) 0.43
diarrhea 18% 10% 0.31
vision disturbance 11% 15% 0.53
dyspnoea 13% 10% 0.69
thrombocytes min. (/nl ± SD) 206 ± 131 177 ± 115 0.48
proteinuria (g/l ± SD) 0.6 ± 1.5 1.3 ± 2.3 0.009
Symptoms are shown in % of patients.as well as viral load are involved [22]. Most European
and Asian cases of hantavirus infection are characterized
by acute renal failure, thrombocytopenia and increased
vascular permeability [19]. Acute renal failure is observed
in 90–95% of infections with Old World hantaviruses. The
long-term prognosis of nephropathia epidemica (NE)
caused by Puumala virus is favorable and most patients
fully recover renal function [19].
Several previous studies reported an association of
pro-inflammatory cytokines and severity of hantavirus
infections [14,23-26]. There are only few reports about
the role of anti-inflammatory and suppressive cytokines
such as TGF-β in hantavirus infection. Temonen et al.Table 2 Laboratory data and cytokine analysis of patients
with mild and severe disease on admission
Parameters Mild disease
(n = 38)
Severe disease
(n = 39)
p-value
creatinine (mg/dl) 2.41 ± 1.9 5.6 ± 2.6 <0.0001
leukocyte (/nl) 8.6 ± 2.6 9.6 ± 3.7 0.55
thrombocytes (/nl) 342 ± 156 232 ± 136 <0.0001
CRP (mg/l) 40 ± 36 62 ± 45 <0.0001
TGF-β1 (ng/ml) 118 ± 47 74 ± 28 0.0001
TGF-β1/Cr 76 ± 60 17 ± 10 <0.0001
TGF-β2 (pg/ml) 586 ± 155 479 ± 146 0.004
TGF-β2/Cr 384 ± 283 110 ± 68 <0.0001
sCD30 (U/ml) 104 ± 63 126 ± 71 0.17
sCD30/Cr 60 ± 48 29 ± 29 0.0002
neopterin (nmol/l) 172 ± 246 186 ± 227 0.41
neopterin/Cr 70 ± 99 36 ± 37 0.04
Figure 2 Serum TGF-β1, TGF-β2 concentration, thrombocyte count and CRP in patients with mild or severe Puumala virus infection.
Values are given for the time on admission and one week after admission.
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pathia epidemica and described an increased expression
of the cytokines TNF-α, TGF-β, and platelet-derived
growth factormainly in the peritubular area of the distal
nephron. Concomitantly also at the same location ex-
pression of the endothelial adhesion molecules ICAM-1,
VCAM, and PECAM was seen [27]. Similarly, it was
shown in a more recent study of deer mice infected with
Sin Nombre virus, that TGF-β1 expressing regulatory
T cells may play an important role in limiting immuno-
pathology in the natural reservoir host, but this response
may interfere with viral clearance [28]. In a previous
study it was shown that disease severity characterized
by elevated creatinine and low platelet counts was corre-
lated with high pro-inflammatory IL-6 and TNF-α but
low immunosuppressive TGF-β1 levels and vice versa,Table 3 Mean and median serum values of TGF-β1, TGF-β2,
and TGF-β/Cr ratios
TGF-β Acute phase
(n = 39)
One week
follow-up (n = 29)
p-value
TGF-β1 (ng/ml; mean ± SD) 74 ± 28 89 ± 39 0.020
TGF-β1 (ng/ml; median) 74 86 0.020
TGF-β2 (pg/ml; mean ± SD) 479 ± 146 533 ± 118 0.008
TGF-β2 (pg/ml; median) 488 534 0.008
TGF-β1/Cr (mean ± SD) 17 ± 10 37 ± 40 0.020
TGF-β1/Cr (median) 13 22 0.020
TGF-β2/Cr (mean ± SD) 110 ± 68 212 ± 197 0.008
TGF-β2/Cr (median) 88 117 0.008
Cr: creatininesuggesting the induction of a protective immune mech-
anism to downregulate or even prevent a massive
pro-inflammatory immune response [14]. Klempa et al.
described mild and severe cases of hemorrhagic fever
with renal syndrome in patients infected with Dobrava-
Belgrade virus in Russia [29]. In accordance with our re-
sults, they found a high number of patients with head-
ache in severe hantavirus infection and elevated
creatinine in severe course of the disease. In the currentFigure 3 ROC curve analysis of TGF-β1, TGF-β2, TGF-β1/Cr,
and TGF-β2/Cr.
Figure 4 Neighbor-joining phylogenetic tree (TN93 evolutionary model) of human Puumala virus (PUUV) strains based on partial
sequences of the S segment (504 nt, position 392–894). PUUV-sequence from strain Sotkamo was used as an outgroup. Sequences taken
from GenBank are indicated by their accession numbers. The numbers 04 to 12 in front of the sample names indicate the year (2004–2012) when
the sample was collected. Four sequences obtained in this study are colored in red (acc.-no.: KM013472-KM013475) and an additional sample
(in blue) was published in an earlier study [Reference PMID: 22958255]. Phylogenetic clades are described earlier [Reference PMID: 22932394].
Scale bar indicates an evolutionary distance of 0.1 substitutions per position.
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TGF-ß2 as major protective markers of hantavirus infec-
tion. With increased production in patients with severe
disease as a response to inflammation [30,31], TGF-β1
and TGF-β2 serum levels reached similar levels in both
patient groups one week after admission. Obviously, pa-
tients with severe disease generate TGF-ß delayed com-
pared to patients with mild disease allowing stronger
proinflammatory cytokine responses and inflammation
in these patients.
TGF-β has a pivotal function in the immune system
and controls the initiation and resolution of inflamma-
tory responses through the regulation of chemotaxis, ac-
tivation, and survival of lymphocytes, natural killer cells,
dendritic cells, macrophages, mast cells, and granulo-
cytes [32]. There are reports of increased TGF-β during
many viral infections, such as influenza, HIV, hepatitis B
virus and hepatitis C virus infection. The neuraminidase
glycoprotein of influenza A and B viruses have been
shown to directly activate latent TGF-β [32]. Prognosticand predictive values of TGF-β in acute viral infections
have not been studied.
In a macaques model of hantavirus infection, Sironen
et al. showed that viral RNA was observed in kidney,
spleen and liver tissues. Inflammatory cell infiltrations
and tubular damage were found in the kidneys, and
these infiltrations contained mainly CD8 T-cells [33]. As
reported by Rook et al., TGF-β exerts profound inhibi-
tory effects on T and B lymphocyte proliferation [34].
T regulatory (Treg)- and T suppressor (Ts)-mediated im-
munosuppression appears to depend on two pathways:
cell–cell contact and cytokine secretion, whereby cyto-
kine secretion is assumed to be more important. Intra-
cellular cytokines, such as interferon (IFN)-γ, IL-10 and
TGF-β are characteristic for certain Treg subsets and
are related with induced Treg function. Stimulation by
mitogens significantly induce TGF-β+-Treg and -Ts.
Tregs are an important component in regulating the
magnitude of the immune response to infection, thus
preventing excessive inflammation and tissue damage
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secreting Treg are forming the first line of immunoregu-
latory T cells during an initiated immune response,
followed by IL-2−, IL-10+, or TGF-β+ Treg. Thus, high
serum levels of TGF-βs during the acute phase and con-
valescence period of hantavirus infection might be a pro-
tective parameter against pro-inflammatory cytokines
and endothelial injury. We found a positive correlation
of both TGF-βs with platelet counts and GFR. In con-
trast to TGF-βs, serum sCD30 and neopterin showed no
significant correlation with main symptoms of disease.
Analysis of cytokines responses during the acute phase
in our studied patients revealed a significant difference
between patients with mild and severe disease. We
showed associations of serum TGF-βs and TGF-βs/Cr
ratios during the acute phase of hantavirus infection
with GFR and disease severity. Severe anti-inflammatory
response was associated with relatively mild disease
whereas weak reactions were associated with severe
renal failure. These data suggest that plasma TGF-βs
levels and especially TGF-βs/Cr ratios during the acute
phase of hantavirus infections may serve as a determin-
ing factor of disease severity that allow prediction of dis-
ease severity.
CRP is an acute phase protein, and during acute phase
of NE, an increase in the serum CRP concentration is
a typical laboratory finding [12]. The known main func-
tions of CRP are complement activation, enhancement of
phagocytosis, and induction of cytokine synthesis. Al-
though the CRP level is widely used as an indicator of the
severity of the disease in various infections, there are no
reports associating high CRP levels with severe disease in
NE or other viral infections. Outinen et al. showed that
high plasma IL-6 concentrations are associated with a
clinically severe acute Puumala hantavirus infection,
whereas, high plasma CRP as such does not reflect the se-
verity of the disease [12]. However, in the present study
serum CRP was a hallmark of kidney injury.
In order to analyse a relationship of these findings to a
distinct hantavirus genotype circulating in the Heidelberg
area, phylogenetic analysis of hantavirus strains was per-
formed. The data revealed no unique hantavirus strain
in these patients and indicate a heterogeneous strain
reservoir in Southwest Germany. Some hantavirus strains
showed the highest relatedness to strains from the
Spessart forest or the Bavarian forest and none of the se-
quenced strains was similar to the Heidelberg strain pub-
lished previously.
Conclusions
We conclude that measurement of TGF-βs and especially
TGF-βs/Cr ratios in the early phase of Puumala hantavirus
infection are very sensitive markers of kidney damage
and that high expression of TGF-β1 and TGF-β2 areassociated with milder courses of hantavirus infection.
High CRP is a marker of disease severity in hantavirus in-
fection. Our results support the hypothesis of an immune-
mediated pathogenesis of hantavirus infection.
Methods
Study population
In this retrospective study, we analyzed clinical and
laboratory data of 77 hospitalised patients diagnosed
with acute hantavirus infection at the University Hospital
Heidelberg. Glomerular filtration rate (GFR) provides the
best index of overall kidney function and creatinine con-
centration is the most widely used parameter for estima-
tion of GFR [8]. Based on GFR, we divided patients into
two groups: patients with mild disease (GFR ≥ 30 ml/min)
and patients with severe disease (GFR < 30 ml/min). The
first blood sample of each patient was obtained on admis-
sion to the hospital, on average 7 days after onset of symp-
toms. An additional blood sample was obtained one week
after admission. All samples were analysed for cytokine
and lymphocyte, monocyte/macrophage activating and in-
flammatory marker expression including transforming
growth factor (TGF)-β1, −β2, −β3, sCD30 and neopterin
levels. The mean age of patients was 40.8 years, 52 were
male (68%), five (6%) were under the age of 18 years.
Detection of hantavirus antibodies and RNA
Sera were tested for hantavirus IgG and IgM antibodies
using the recomLine hantavirus assay (Mikrogen, Munich,
Germany), coated with specific hantavirus nucleocapsid
antigens of Puumala virus, Dobrava-Belgrade virus,
Hantaan virus and Seoul virus. Patients were included in
the study if both, hantavirus IgG and IgM were positive.
Positive results of IgG and negative results of IgM for
hantavirus may also indicate an infection with mild clin-
ical symptoms. However, for these patients with positive
IgG and negative IgM for hantavirus, reference samples
were available indicating no acute but past hantavirus in-
fection. Consequently, these patients had been excluded
from the study. PCR for the detection of hantavirus RNA
was performed on the L-segment [36]. For phylogenetic
analysis positive samples were subsequently sequenced in
the S-segment [18]. Characteristics of the sequence ana-
lysis are given in the legend to the figure.
Determination of serum cytokines and CRP
TGF-β1, β2 and β3 were measured with the Luminex
TGF assay (R&D Systems, Wiesbaden, Germany). To ex-
clude cytokine accumulation due to dysfunction of renal
excretion, cytokine/creatinine ratios were calculated. For
ease of viewing, TGF-β1 is shown in ng/ml, whereas TGF-
β2 and TGF-β3 are shown in pg/ml. Serum neopterin was
measured with the Neopterin ELISA kit (Brahms, Berlin,
Germany). Based on control measurements in 36 healthy
Sadeghi et al. BMC Immunology  (2015) 16:19 Page 7 of 8individuals, neopterin concentrations >15 nmol/l is con-
sidered above normal range. Sera were tested for serum
sCD30 content using a commercially available ELISA kit
(Bender MedSystems, Vienna, Austria). All cytokines,
neopterin and CRP were determined on admission of the
patients to the hospital and one week after admission.
Statistical analysis
Categorical and continuous variables were analyzed
using chi square, Fisher exact and Mann–Whitney-U
tests. Statistical analyses were performed with the Statis-
tical Package for the Social Sciences (SPSS, 18.0). After
Bonferroni correction, p values ≤0.05 were considered
statistically significant.
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